Skip to main content

A25 (Erythromycin Delayed Release 250 mg)

Pill with imprint A25 is White, Elliptical/Oval and has been identified as Erythromycin Delayed Release 250 mg. It is supplied by Torrent Pharmaceuticals Limited.

Erythromycin is used in the treatment of bronchitis; bacterial endocarditis prevention; bowel preparation; bartonellosis; otitis media and belongs to the drug class macrolides. There is no proven risk in humans during pregnancy. Erythromycin 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for A25

Erythromycin Delayed Release

Imprint
A25
Strength
250 mg
Color
White
Size
15.00 mm
Shape
Elliptical/Oval
Availability
Prescription only
Drug Class
Macrolides
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Torrent Pharmaceuticals Limited
Manufacturer
Appco Pharma LLC
National Drug Code (NDC)
13668-0586
Inactive Ingredients
calcium silicate, silicon dioxide, croscarmellose sodium, hydroxypropyl cellulose, hypromellose 2208 (100 mPa.s), magnesium stearate, mannitol, methacrylic acid - ethyl acrylate copolymer (1:1) type a, poloxamer 407, polyethylene glycol, corn starch, sodium bicarbonate, sodium citrate, sodium lauryl sulfate, talc, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related images for "A25"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.